Company Filing History:
1 out of 95 
1 out of 4 Years Active: 2023
Title: The Innovations of Bernard Roy in Obesity Treatment
Introduction
Bernard Roy is an innovative inventor based in Cork, Ireland. He has made significant contributions to the field of obesity treatment and weight management. His research focuses on the development of a specific strain, which has shown promising results in managing weight and improving metabolic health.
Latest Patents
Bernard Roy holds a patent for a strain known as APC 1472. This strain has demonstrated weight-lowering effects in vivo by inducing satiety through decreased internalization of the Ghrelin receptor. Consequently, this leads to reduced constitutive activity. Additionally, the strain has shown a trend towards decreased ghrelin receptor hypothalamic expression in high-fat diet-fed mice compared to the vehicle control group. Furthermore, it improves glucose tolerance and decreases insulin plasma levels in mice, indicating its potential in the prevention and treatment of Type II diabetes, particularly in obese individuals.
Career Highlights
Throughout his career, Bernard Roy has worked with notable institutions such as University College Cork and the Agriculture and Food Development Authority (Teagasc). His work has been pivotal in advancing research in obesity and metabolic disorders.
Collaborations
Bernard has collaborated with esteemed colleagues, including John Francis Cryan and Ted Dinan, who have contributed to his research endeavors.
Conclusion
Bernard Roy's innovative work in obesity treatment through the development of the APC 1472 strain highlights his commitment to addressing significant health challenges. His contributions are paving the way for new approaches in weight management and diabetes prevention.